Irmela Mantel Selected Research

Paraneoplastic Syndromes (Paraneoplastic Syndrome)

12/2015

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irmela Mantel Research Topics

Disease

30	Macular Degeneration (Age-Related Maculopathy) 03/2022 - 01/2007
6	Atrophy 07/2022 - 11/2011
5	Central Serous Chorioretinopathy 10/2022 - 09/2010
4	Choroidal Neovascularization 01/2019 - 03/2009
2	Retinal Detachment (Retinal Detachments) 10/2022 - 10/2014
2	Neoplasms (Cancer) 12/2015 - 10/2014
1	COVID-19 01/2022
1	Weight Loss (Weight Reduction) 01/2020
1	Vision Disorders (Hemeralopia) 01/2019
1	Pain (Aches) 01/2018
1	Telangiectasis (Telangiectasia) 12/2017
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 12/2015
1	Toxic Optic Neuropathy 12/2015
1	Ischemia 10/2014
1	Uveal melanoma 10/2014
1	Endophthalmitis (Ophthalmia) 01/2014
1	Inflammation (Inflammations) 01/2014
1	Cysts 03/2013
1	Fibrosis (Cirrhosis) 11/2011
1	Hemorrhage 11/2011
1	Eye Diseases (Eye Disease) 01/2010
1	Idiopathic Juxtafoveal Retinal Telangiectasia 11/2009
1	Myopia 03/2009

Drug/Important Bio-Agent (IBA)

20	Ranibizumab (Lucentis)FDA Link 08/2020 - 01/2008
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 01/2007
11	afliberceptIBA 08/2020 - 10/2015
8	Retinaldehyde (Retinal)IBA 07/2022 - 09/2009
3	Retinal Pigments (Pigments, Visual)IBA 11/2021 - 11/2011
2	Endothelial Growth FactorsIBA 09/2018 - 01/2010
2	Pharmaceutical PreparationsIBA 05/2016 - 10/2015
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Vascular Endothelial Growth FactorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2019
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	AntigensIBA 12/2015
1	AntibodiesIBA 12/2015
1	Bevacizumab (Avastin)FDA Link 10/2014
1	Complement Factor B (Factor B)IBA 03/2014
1	Complement System Proteins (Complement)IBA 03/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014

Therapy/Procedure

8	Intravitreal Injections 03/2022 - 03/2009
5	Injections 03/2022 - 01/2007
4	Therapeutics 10/2022 - 01/2010
4	Retreatment 01/2019 - 03/2013
1	Aftercare (After-Treatment) 10/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020
1	Radiotherapy 12/2015
1	Proton Therapy 10/2014
1	Lasers (Laser) 10/2014
1	Light Coagulation 10/2014